Page last updated: 2024-08-21

4-amino-3-phenylbutyric acid and Disease Models, Animal

4-amino-3-phenylbutyric acid has been researched along with Disease Models, Animal in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belozertseva, I; Danysz, W; Franke, L; Nagel, J; Valastro, B1
Khozhai, LI; Otellin, VA; Tyurenkov, IN1
Goncharenko, NV; Pankrat'ev, DV; Talalaenko, AN1
Lebedeva, SA; Perfilova, VN; Tiurenkov, IN1
Chesnokova, IaM; Filimonov, VG; Sheveleva, GA; Sizov, PI1

Other Studies

5 other study(ies) available for 4-amino-3-phenylbutyric acid and Disease Models, Animal

ArticleYear
Optical isomers of phenibut inhibit [H(3)]-Gabapentin binding in vitro and show activity in animal models of chronic pain.
    Pharmacological reports : PR, 2016, Volume: 68, Issue:3

    Topics: Amines; Animals; Chronic Pain; Cyclohexanecarboxylic Acids; Disease Models, Animal; Freund's Adjuvant; Gabapentin; gamma-Aminobutyric Acid; Hypersensitivity; Male; Pain Measurement; Radioligand Assay; Rats; Stereoisomerism

2016
[THE EFFECT OF PERINATAL HYPOXIA ON THE STRUCTURE OF BLOOD-BRAIN BARRIER IN RATS TREATED WITH SALIFEN].
    Morfologiia (Saint Petersburg, Russia), 2015, Volume: 148, Issue:6

    Topics: Animals; Animals, Newborn; Blood-Brain Barrier; Capillaries; Disease Models, Animal; Endothelium, Vascular; gamma-Aminobutyric Acid; Hypoxia, Brain; Microscopy, Electron; Neuroprotective Agents; Rats

2015
Neurochemical characteristics of the ventromedial hypothalamus in mediating the antiaversive effects of anxiolytics in different models of anxiety.
    Neuroscience and behavioral physiology, 2003, Volume: 33, Issue:3

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Anti-Anxiety Agents; Anticonvulsants; Anxiety; Apomorphine; Avoidance Learning; Biguanides; Brain Chemistry; Chlordiazepoxide; Clonidine; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Droperidol; Drug Interactions; GABA Agents; GABA Antagonists; GABA Modulators; gamma-Aminobutyric Acid; Glutamic Acid; Male; Memantine; Mephenytoin; Microinjections; Pentylenetetrazole; Phentolamine; Picrotoxin; Piperazines; Propranolol; Pyrimidines; Rats; Serotonin; Sulpiride; Ventromedial Hypothalamic Nucleus; Yohimbine

2003
[Correction of cardiotoxic effect of chronic alcoholic intoxication by GABA-ergic compounds].
    Kardiologiia, 2007, Volume: 47, Issue:6

    Topics: Alcoholism; Animals; Disease Models, Animal; Drug Therapy, Combination; GABA Agents; gamma-Aminobutyric Acid; Heart; Male; Myocardial Contraction; Nootropic Agents; Piracetam; Rats; Treatment Outcome; Ventricular Pressure

2007
[Experimental study of the effects of fenibut and seduxen on fetal development in the last third of pregnancy].
    Akusherstvo i ginekologiia, 1991, Issue:5

    Topics: Abortion, Threatened; Animals; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Embryonic and Fetal Development; Female; gamma-Aminobutyric Acid; Gestational Age; Pregnancy; Rats; Tranquilizing Agents

1991